Article: article from journal or magazin.
Corrective use of the 2.5-mm GFX stent for suboptimal angioplasty results in small coronary arteries
Catheterization and Cardiovascular Interventions
Journal Article --- Old month value: Oct
To evaluate the clinical efficacy of endoluminal stenting in the setting of percutaneous intervention for small coronary artery lesions, we reviewed our results on stenting with the 2.5-mm GFX stent (Arterial Vascular Engineering, Santa Rosa, CA) during an 18-month study period. A total of 120 patients with significant coronary artery disease in vessels </=2.6 mm were followed up clinically. Procedural success (defined as angiographic residual stenosis <20% without clinical complications) was obtained in 94% of cases. In-hospital complications were death (1%), non-Q-wave myocardial infarction (5%), and urgent repeat percutaneous intervention because of stent thrombosis (3%). During a mean follow-up of 9.8 months (range, 6-23 months), the following complications were noted: myocardial infarction (1%), clinical need for repeat intervention (13%) requiring repeat percutaneous treatment (12%) and surgical revascularization (1%). In conclusion, transcatheter application of a specifically designed stent for coronary artery disease in small vessels seems safe and efficient with a low incidence of adverse events during follow-up. Cathet. Cardiovasc. Intervent. 48:157-161, 1999.
Adult Aged Aged, 80 and over Angioplasty, Transluminal, Percutaneous Coronary/*instrumentation Coronary Angiography Coronary Disease/mortality/radiography/*therapy Female Follow-Up Studies Graft Occlusion, Vascular/mortality/radiography/*therapy Hospital Mortality Humans Male Middle Aged Prosthesis Design Prosthesis Failure Retreatment *Stents Treatment Outcome
Web of science
Last modification date